Tilo Großer
Impact in
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 43
- Inflammatory mediators and NSAID effects 43
- Pharmacogenetics and Drug Metabolism 6
- Biochemistry 17
- Eicosanoids and Hypertension Pharmacology 17
- Co-authors
- Garret A. FitzGeraldYing YuJohn A. LawsonEmanuela RicciottiEmer M. SmythMiao WangSandra AustinThomas M. Coffman
- Journals
- Circulation (5 papers)European Journal of Pharmacology (3 papers)Science (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Tilo Großer
69 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Pharmacology 2.2k
- Biochemistry 855
- Aging 99
- Endocrine and Autonomic Systems 377
- Pharmacology 460
Countries citing papers authored by Tilo Großer
This map shows the geographic impact of Tilo Großer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilo Großer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilo Großer more than expected).
Fields of papers citing papers by Tilo Großer
This network shows the impact of papers produced by Tilo Großer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilo Großer. The network helps show where Tilo Großer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tilo Großer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 38 | |
| 3 | 2020 | 63 | |
| 4 | 2019 | 25 | |
| 5 | 2018 | 25 | |
| 6 | 2017 | 106 | |
| 7 | 2016 | 26 | |
| 8 | 2012 | 132 | |
| 9 | 2012 | 153 | |
| 10 | 2010 | 1 | |
| 11 | 2009 | 10 | |
| 12 | 2009 | 14 | |
| 13 | 2008 | 113 | |
| 14 | 2006 | 66 | |
| 15 | 2006 | 47 | |
| 16 | Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities Hit paper breakdown → | 2005 | 792 |
| 17 | 2005 | 33 | |
| 18 | Developmental Expression of Functional Zebrafish Cyclooxygenases | 2003 | 1 |
| 19 | 2001 | 15 | |
| 20 | 1998 | 50 |
About Tilo Großer
Tilo Großer is a scholar working on Pharmacology, Biochemistry, Aging, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 70 papers that have together received 6.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (43 papers), Eicosanoids and Hypertension Pharmacology (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (16 papers), Estrogen and related hormone effects (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Nitric Oxide and Endothelin Effects (5 papers), Circadian rhythm and melatonin (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Pharmacology (2.2k citations), Biochemistry (855 citations), Aging (99 citations), Endocrine and Autonomic Systems (377 citations) and Pharmacology (460 citations). Tilo Großer has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Garret A. FitzGerald, Ying Yu, John A. Lawson, Emanuela Ricciotti, Emer M. Smyth, Miao Wang, Sandra Austin, Thomas M. Coffman, Yan Cheng and Beverly H. Koller. Their work appears in journals such as Circulation, European Journal of Pharmacology, Science, Clinical Pharmacology & Therapeutics and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.